No Data
No Data
Xanamem: Alzheimer's Breakthrough Set for 2025, 2026
Actinogen Reports Busy 6 Months as Development of Xanamem Molecule Ramps up
Actinogen Medical Ltd: ACW HY25 results Advancing to latestage clinical development
Actinogen Medical Ltd: Actinogen HY2025 financial report and Appendix 4D
Investors in Actinogen Medical (ASX:ACW) Have Unfortunately Lost 76% Over the Last Three Years
Actinogen Medical Doses First Participant in Alzheimer's Disease Trial in US; Shares Rise Nearly 7%
151479178 : What are you talking about